文献速递泌尿生殖骨肌技术与安全PETCTMR

单中心前瞻性评估68Ga-PSMA-11 PET在前列腺癌生化复发中的价值

Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2019-04-30

单中心前瞻性研究纳入150例放疗或前列腺切除术后生化复发的前列腺癌患者,行68Ga-PSMA-11 PET/CT或PET/MRI,两名盲法判读医师按区域评估。结果显示区域间读者信度κ=0.78-0.87,区域敏感度最高达100%、患者水平最高达89.8%,阳性预测值区域最高达100%、患者水平最高达91.5%。

要点

  • 骨转移敏感度和阳性预测值最高,软组织转移敏感度最低,前列腺床复发阳性预测值最低。
  • 区域间读者信度κ=0.78-0.87,达实质至几乎完美一致。

核心结论

  • 68Ga-PSMA-11 PET对生化复发前列腺癌患者的转移灶敏感,阳性预测值高,读者间信度达实质至几乎完美一致。

研究设计与样本

  • 单中心前瞻性研究,150例生化复发前列腺癌患者行68Ga-PSMA-11 PET/CT或PET/MRI,两名盲法委员会认证放射科医师判读,以病理或影像联合临床随访为参考标准。

关键影像表现/征象

  • 按区域评估PSMA阳性病变位于前列腺床、盆腔淋巴结、骨骼及软组织(盆腔外淋巴结和内脏结构)。
  • 骨转移敏感度最高,软组织转移敏感度最低;骨转移阳性预测值最高,前列腺床复发阳性预测值最低。

诊断标准与关键数值

  • 区域间读者信度κ=0.78-0.87。
  • 区域敏感度最高达100%,患者水平敏感度最高达89.8%。
  • 区域阳性预测值最高达100%,患者水平阳性预测值最高达91.5%。

临床应用与阅片要点

  • 判读时按前列腺床、盆腔淋巴结、骨骼和软组织分区评估PSMA阳性病变。
  • 骨转移的敏感度和阳性预测值最高,软组织转移敏感度最低,前列腺床复发阳性预测值最低。

局限性

  • 43例有病理相关性,29例采用影像与随访复合标准判断病变有无。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to determine the diagnostic accuracy of 68Ga-labeled prostate-specific membrane antigen 11 (PSMA-11) PET for disease detection in patients with prostate cancer who have biochemically recurrent disease after radiation therapy or prostatectomy. SUBJECTS AND METHODS. One hundred fifty patients underwent 68Ga-PSMA-11 PET/CT or PET/MRI, and the images were interpreted by two blinded board-certified radiologists. Each reader evaluated for the presence or absence of PSMA-positive disease within the prostate bed, pelvic lymph nodes, bones, and soft tissues (extrapelvic lymph nodes and visceral structures). The presence or absence of disease was confirmed by histopathologic analysis if available. For patients who did not have pathologic analysis, a composite of imaging and clinical follow-up was used as the reference standard. RESULTS. The median prostate-specific antigen level was 2.1 ng/mL. Forty-three patients had pathologic correlation, and for 29 patients a composite of imaging and follow-up was used to determine the presence or absence of disease. With substantial to almost perfect interreader reliability by region (κ = 0.78-0.87), 68Ga-PSMA-11 PET had high sensitivity per region (up to 100%) and per patient (up to 89.8%). It also had high positive predictive value per region (up to 100%) and per patient (up to 91.5%). Sensitivity was highest for bone metastases and lowest for soft-tissue metastases. Positive predictive value was highest for bone metastases and lowest for prostate bed recurrence. CONCLUSION. Gallium-68-labeled PSMA-11 PET is sensitive for prostate cancer metastases in patients with biochemically recurrent prostate cancer. It has high positive predictive value and substantial to almost perfect interrater reliability.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lawhn-Heath C, Flavell RR, Behr SC, et al. Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer. AJR Am J Roentgenol. 2019. PMID: 31039025. doi:10.2214/AJR.18.20699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。